Skip to content
Thursday, May 14, 2026
  • NFL nixed minority offensive asst. mandate in '25
  • House passes bill for year-round E15 ethanol fuel sales, splitting Republicans
  • Polestar CEO tells CNBC ‘pump anxiety’ has made EVs ‘all about money’
  • 🏀 How OKC built a drama-free potential dynasty
https://ukusanews.com/

UK & USA NEWS

Newsletter
Random News
  • Poltics
  • Sports
  • Entertainment
  • Business
  • Health
  • Tech
  • Biography
  • World
  • NFL nixed minority offensive asst. mandate in '25
  • House passes bill for year-round E15 ethanol fuel sales, splitting Republicans
  • Polestar CEO tells CNBC ‘pump anxiety’ has made EVs ‘all about money’
  • 🏀 How OKC built a drama-free potential dynasty
https://ukusanews.com/

UK & USA NEWS

Newsletter
Random News
  • Poltics
  • Sports
  • Entertainment
  • Business
  • Health
  • Tech
  • Biography
  • World
Headlines
  • NFL nixed minority offensive asst. mandate in '25

    28 seconds ago
  • House passes bill for year-round E15 ethanol fuel sales, splitting Republicans

    23 minutes ago
  • Polestar CEO tells CNBC ‘pump anxiety’ has made EVs ‘all about money’

    56 minutes ago
  • 🏀 How OKC built a drama-free potential dynasty

    1 hour ago
  • Administration threatens to withhold Medicaid funding over fraud prosecutions

    1 hour ago
  • UK Labour leadership challenge: Starmer rivals line up

    2 hours ago
  • Transfer rumors, news: Man United revive interest …

    2 hours ago
  • Almost half strongly oppose AI data centers in their area: Gallup

    2 hours ago
  • what it means for China markets

    3 hours ago
  • Amid slump, Ohtani stars again on mound in win

    3 hours ago
  • Home
  • Novo Nordisk A/S (B Shares) ADRhedged

Novo Nordisk A/S (B Shares) ADRhedged

  • Business

Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India

Sagar1 month ago04 mins

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The market share of India’s most popular weight‑loss drugmaker, Eli Lilly, slipped in March, while rival Novo Nordisk held steady even as Indian generic drugmakers flooded the market with lower‑priced copies. Eli Lilly’s Indian market share in the GLP‑1 category of…

Read More
  • Business

FDA approves first GLP-1 pill for obesity from Novo Nordisk

Sagar5 months ago02 mins

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Novo Nordisk, a landmark decision that health experts say could…

Read More

Recent Posts

  • NFL nixed minority offensive asst. mandate in '25
  • House passes bill for year-round E15 ethanol fuel sales, splitting Republicans
  • Polestar CEO tells CNBC ‘pump anxiety’ has made EVs ‘all about money’
  • 🏀 How OKC built a drama-free potential dynasty
  • Administration threatens to withhold Medicaid funding over fraud prosecutions

Recent Comments

  1. Visit This Link on Trump Applauds Massive Russia-Ukraine Prisoner Swap, Hints at ‘Something Big’ in Peace Talks
  2. Buy SEO Backlinks on Trump Applauds Massive Russia-Ukraine Prisoner Swap, Hints at ‘Something Big’ in Peace Talks
  3. Birkin Hotsell Yellow Bag on Trump Applauds Massive Russia-Ukraine Prisoner Swap, Hints at ‘Something Big’ in Peace Talks
  4. scar removal treatment on LA Riots: Can Trump Send in the National Guard? Here’s What the Insurrection Act Says
  5. affordable insurance coverage on Russia-Ukraine War: Is a Ceasefire Near? Trump Plans to Call Putin and Zelensky

Archives

  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025

Categories

  • Biography
  • Business
  • Entertainment
  • Health
  • Poltics
  • Sports
  • Tech
  • World
Copyright [2026] | Powered by ukusanews.com Powered By BlazeThemes.
  • About Us
  • Contect Us
  • Fact checking Policy
  • DNAPA Code of Ethics
  • Correction Policy
  • Privacy Policy